In pancreatic cancer, IGF2BP2 has been implicated as a reader to regulate lncRNA DANCR, leading to cell viability and proliferation, and stemness-like properties (Hu et al., 2020). This evidence concerns the gene IGF2BP2 and pancreatic neoplasm.